Primary Hyperparathyroidism and the Kidney

Munro Peacock

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

The kidney occupies a unique position in primary hyperparathyroidism (PHPT). It is largely responsible for setting the concentration of calcium and phosphate in extracellular fluid and determining active transport of dietary calcium and phosphate. It does so by virtue of the action of PTH on the renal tubule to regulate reabsorption of calcium and phosphate, and to control the secretion rate of 1,25-dihydroxyvitamin D. Measurement of calcium and phosphate processing by the kidney is essential for diagnosis and management of PHPT. Hypercalcemia with hyperparathyroidemia is the diagnostic biochemical feature of PHPT. Drugs acting on the kidney and chronic renal failure modify the serum biochemical and tissue manifestations of the disease. The kidney is one of the few organs that unequivocally manifest primary hyperparathyroid disease clinically. Abnormalities in urinary and pre-urinary risk factors in PHPT increase the risk of recurrent renal stone formation and nephrocalcinosis.

Original languageEnglish
Title of host publicationThe Parathyroids: Basic and Clinical Concepts: Third Edition
PublisherElsevier Inc.
Pages455-467
Number of pages13
ISBN (Print)9780123971661
DOIs
StatePublished - Sep 5 2014

Fingerprint

Primary Hyperparathyroidism
Kidney
Nephrocalcinosis
Active Biological Transport
Extracellular Fluid
Hypercalcemia
Chronic Kidney Failure
calcium phosphate
Serum
Pharmaceutical Preparations

Keywords

  • 1,25-dihydroxyvitamin D
  • Fibroblast growth factor 23
  • Nephrocalcinosis
  • Parathyroid hormone
  • Renal stone
  • Renal tubular calcium reabsorption
  • Renal tubular phosphate reabsorption
  • Urine calcium
  • Urine phosphate

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Peacock, M. (2014). Primary Hyperparathyroidism and the Kidney. In The Parathyroids: Basic and Clinical Concepts: Third Edition (pp. 455-467). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-397166-1.00031-X

Primary Hyperparathyroidism and the Kidney. / Peacock, Munro.

The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc., 2014. p. 455-467.

Research output: Chapter in Book/Report/Conference proceedingChapter

Peacock, M 2014, Primary Hyperparathyroidism and the Kidney. in The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc., pp. 455-467. https://doi.org/10.1016/B978-0-12-397166-1.00031-X
Peacock M. Primary Hyperparathyroidism and the Kidney. In The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc. 2014. p. 455-467 https://doi.org/10.1016/B978-0-12-397166-1.00031-X
Peacock, Munro. / Primary Hyperparathyroidism and the Kidney. The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc., 2014. pp. 455-467
@inbook{b8880dd4eb114ff69f798a9a63b34f7f,
title = "Primary Hyperparathyroidism and the Kidney",
abstract = "The kidney occupies a unique position in primary hyperparathyroidism (PHPT). It is largely responsible for setting the concentration of calcium and phosphate in extracellular fluid and determining active transport of dietary calcium and phosphate. It does so by virtue of the action of PTH on the renal tubule to regulate reabsorption of calcium and phosphate, and to control the secretion rate of 1,25-dihydroxyvitamin D. Measurement of calcium and phosphate processing by the kidney is essential for diagnosis and management of PHPT. Hypercalcemia with hyperparathyroidemia is the diagnostic biochemical feature of PHPT. Drugs acting on the kidney and chronic renal failure modify the serum biochemical and tissue manifestations of the disease. The kidney is one of the few organs that unequivocally manifest primary hyperparathyroid disease clinically. Abnormalities in urinary and pre-urinary risk factors in PHPT increase the risk of recurrent renal stone formation and nephrocalcinosis.",
keywords = "1,25-dihydroxyvitamin D, Fibroblast growth factor 23, Nephrocalcinosis, Parathyroid hormone, Renal stone, Renal tubular calcium reabsorption, Renal tubular phosphate reabsorption, Urine calcium, Urine phosphate",
author = "Munro Peacock",
year = "2014",
month = "9",
day = "5",
doi = "10.1016/B978-0-12-397166-1.00031-X",
language = "English",
isbn = "9780123971661",
pages = "455--467",
booktitle = "The Parathyroids: Basic and Clinical Concepts: Third Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Primary Hyperparathyroidism and the Kidney

AU - Peacock, Munro

PY - 2014/9/5

Y1 - 2014/9/5

N2 - The kidney occupies a unique position in primary hyperparathyroidism (PHPT). It is largely responsible for setting the concentration of calcium and phosphate in extracellular fluid and determining active transport of dietary calcium and phosphate. It does so by virtue of the action of PTH on the renal tubule to regulate reabsorption of calcium and phosphate, and to control the secretion rate of 1,25-dihydroxyvitamin D. Measurement of calcium and phosphate processing by the kidney is essential for diagnosis and management of PHPT. Hypercalcemia with hyperparathyroidemia is the diagnostic biochemical feature of PHPT. Drugs acting on the kidney and chronic renal failure modify the serum biochemical and tissue manifestations of the disease. The kidney is one of the few organs that unequivocally manifest primary hyperparathyroid disease clinically. Abnormalities in urinary and pre-urinary risk factors in PHPT increase the risk of recurrent renal stone formation and nephrocalcinosis.

AB - The kidney occupies a unique position in primary hyperparathyroidism (PHPT). It is largely responsible for setting the concentration of calcium and phosphate in extracellular fluid and determining active transport of dietary calcium and phosphate. It does so by virtue of the action of PTH on the renal tubule to regulate reabsorption of calcium and phosphate, and to control the secretion rate of 1,25-dihydroxyvitamin D. Measurement of calcium and phosphate processing by the kidney is essential for diagnosis and management of PHPT. Hypercalcemia with hyperparathyroidemia is the diagnostic biochemical feature of PHPT. Drugs acting on the kidney and chronic renal failure modify the serum biochemical and tissue manifestations of the disease. The kidney is one of the few organs that unequivocally manifest primary hyperparathyroid disease clinically. Abnormalities in urinary and pre-urinary risk factors in PHPT increase the risk of recurrent renal stone formation and nephrocalcinosis.

KW - 1,25-dihydroxyvitamin D

KW - Fibroblast growth factor 23

KW - Nephrocalcinosis

KW - Parathyroid hormone

KW - Renal stone

KW - Renal tubular calcium reabsorption

KW - Renal tubular phosphate reabsorption

KW - Urine calcium

KW - Urine phosphate

UR - http://www.scopus.com/inward/record.url?scp=84942760627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942760627&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-397166-1.00031-X

DO - 10.1016/B978-0-12-397166-1.00031-X

M3 - Chapter

AN - SCOPUS:84942760627

SN - 9780123971661

SP - 455

EP - 467

BT - The Parathyroids: Basic and Clinical Concepts: Third Edition

PB - Elsevier Inc.

ER -